Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05051566
PHASE1

A Multiple Dose Study of LY3502970 in Healthy Participants

Sponsor: Eli Lilly and Company

View on ClinicalTrials.gov

Summary

The main purpose of this study is to assess how fast LY3502970 gets into the blood stream and how long it takes the body to remove it when administered in multiple oral doses as new formulation compared to that of reference LY3502970 formulation. Information about safety and tolerability will be collected. The study is open to healthy participants. The study is conducted in two parts and it will last up to about 6 months, inclusive of screening period.

Official title: A Multiple Dose Study in Healthy Participants to Investigate the Safety, Tolerability, and Pharmacokinetics of LY3502970

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

26

Start Date

2021-09-16

Completion Date

2022-04-04

Last Updated

2026-05-29

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

LY3502970

Administered orally.

DRUG

Esomeprazole

Administered orally.

Locations (1)

Quotient Clinical Ltd

Nottingham, United Kingdom